...
首页> 外文期刊>Current medical research and opinion >Baseline characteristics and treatment patterns of patients with schizophrenia initiated on once-every-three-months paliperidone palmitate in a real-world setting
【24h】

Baseline characteristics and treatment patterns of patients with schizophrenia initiated on once-every-three-months paliperidone palmitate in a real-world setting

机译:精神分裂症患者的基线特征和治疗模式在真实世界的环境中掌握一次每三个月的帕帕里酮棕榈酸盐

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives: Since May 2015, adult patients with schizophrenia adequately treated with once monthly paliperidone palmitate (PP1M) may be transitioned to once-every-three-months paliperidone palmitate (PP3M). This study aims to describe baseline characteristics and treatment patterns of patients with schizophrenia initiated on PP3M in a real-world setting.
机译:目标:自2015年5月以来,成年患者患有一次性的精神分裂症患者每月每月帕米酮棕榈酸酯(PP1M)可能会转变为每三个月的Paliperidone Palmite(PP3M)。 本研究旨在描述在真实世界环境中对PP3M发起的精神分裂症患者的基线特征和治疗模式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号